Clinical Trial Update: A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy [Phase 1]

View source ↗

Summary

AstraZeneca is conducting a Phase 1 study of AZD4063 for patients with dilated cardiomyopathy, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Drugs mentioned

• AZD4063

Snippet

Sponsor: AstraZeneca | Conditions: Dilated Cardiomyopathy | Phase 1 | Status: RECRUITING